HMGB1 and acute kidney injury: In vitro, paclitaxel could prevent LPS-induced AKI by regulating lncRNA MALAT1/miR-370-3p/HMGB1 axis, suggesting that paclitaxel may be used as a therapeutic drug to reduce sepsis-related AKI (91).